Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Newer generation, clot-busting stroke medication cuts the risk of serious bleeding in half
Categories: Stroke News & Brain Health, Scientific Conferences & Meetings
|
Published: February 03, 2022

Newer generation, clot-busting stroke medication cuts the risk of serious bleeding in half

American Stroke Association International Stroke Conference, Presentation 43
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print

Related Images

Previous Slide Next Slide

Clot busting tPA administered illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association

Download (555.1 kB)
Clot busting tPA administered illustration

Clot busting tPA administered illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (555.1 kB) File Permalink

Clot busted with tPA illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association

Download (558.5 kB)
Clot busted with tPA illustration

Clot busted with tPA illustration

Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived.

About Stroke | Stroke treatments

copyright American Heart Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (558.5 kB) File Permalink

Steven J. Warach M.D. Ph.D.

Steven J. Warach M.D. Ph.D., Professor of Neurology, Dell Medical School at the University of Texas at Austin, Chair of Ascension’s National Stroke Group, Medical Director for Ascension Hospitals in Texas

copyright Dell Medical School, University of Texas at Austin

Download (110.5 kB)
Steven J. Warach M.D. Ph.D.

Steven J. Warach M.D. Ph.D.

Steven J. Warach M.D. Ph.D., Professor of Neurology, Dell Medical School at the University of Texas at Austin, Chair of Ascension’s National Stroke Group, Medical Director for Ascension Hospitals in Texas

copyright Dell Medical School, University of Texas at Austin


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (110.5 kB) File Permalink

ISC Logo

copyright American Stroke Association

Download (62.9 kB)
ISC Logo

ISC Logo

copyright American Stroke Association


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (62.9 kB) File Permalink
  • Clot busting tPA administered illustration
  • Clot busted with tPA illustration
  • Steven J. Warach M.D. Ph.D.
  • ISC Logo

Related Video

Previous Slide Next Slide

Ischemic Stroke with tPA animation

A computer generated graphic of a clot in the brain and the clot-busting drug, tissue plasminogen activator (tPA), working to dissolve the clot and improve blood flow to the part of the brain being deprived. 

About Stroke | Stroke treatments

copyright American Stroke Association

Please do not remove copyright from animation.

 

Download (103.7 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Ischemic Stroke with tPA animation

A computer generated graphic of a clot in the brain and the clot-busting drug, tissue plasminogen activator (tPA), working to dissolve the clot and improve blood flow to the part of the brain being deprived. 

About Stroke | Stroke treatments

copyright American Stroke Association

Please do not remove copyright from animation.

 


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (103.7 MB) File Permalink

Dr. Broderick ISC22-43 clot-buster history-uses

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022

Download (53.2 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Broderick ISC22-43 clot-buster history-uses

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (53.2 MB) File Permalink

Dr. Broderick ISC22-43 ischemic strokes and warning signs

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022

Download (51.4 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Broderick ISC22-43 ischemic strokes and warning signs

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (51.4 MB) File Permalink

Dr. Broderick ISC22-43 study perspective

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022

Download (43.3 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Broderick ISC22-43 study perspective

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (43.3 MB) File Permalink

Dr. Broderick ISC22-43 study limitations-biases

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022

Download (36.6 MB)
Sorry, your browser doesn\'t support embedded videos, download and watch with your favorite video player!

Dr. Broderick ISC22-43 study limitations-biases

Video perspective: American Stroke Association volunteer expert Joseph Broderick, M.D., is professor and director of the UC Gardner Neuroscience Institute, director of the National Coordinating Center for NIH’s StrokeNet, and professor of medicine at the University of Cincinnati College of Medicine. He offers perspective on American Stroke Association's International Stroke Conference 2022 Presentation 43.

News Release

Video Transcript (txt)

copyright American Stroke Association 2022


Please see AHA/ASA Multimedia Materials Usage Policy.

Download (36.6 MB) File Permalink
  • Ischemic Stroke with tPA animation
  • Dr. Broderick ISC22-43 clot-buster history-uses
  • Dr. Broderick ISC22-43 ischemic strokes and warning signs
  • Dr. Broderick ISC22-43 study perspective
  • Dr. Broderick ISC22-43 study limitations-biases
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED